Jeff A. Chou
YOU?
Author Swipe
View article: Supplementary Figure S5 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S5 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
IPA network schematics of regulatory pathways identified by IBE-IBD differentially expressed genes.
View article: Supplementary Figure S4 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S4 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Subgroup analysis in IBE and IBD tumors. Kaplan-Meier plots comparing the probability of DMFS of patients classified as FID, WID and PID.
View article: Supplementary Figure S3 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S3 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Differential abundance of immune cell infiltrate in FID and PID breast tumors.
View article: Data from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Data from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
The abundance and functional orientation of tumor-infiltrating lymphocytes in breast cancer is associated with distant metastasis-free survival, yet how this association is influenced by tumor phenotypic heterogeneity is poorly understood.…
View article: Supplementary Figure S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Cross-cohort comparisons of metagene distributions and tertile thresholds.
View article: Supplementary Figure S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Cross-cohort comparisons of metagene distributions and tertile thresholds.
View article: Supplementary Figure S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
The B/P, T/NK and M/D immune metagenes are coordinately expressed in breast tumors and leukocytes but not in breast cancer cell lines.
View article: Supplementary Figure S5 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S5 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
IPA network schematics of regulatory pathways identified by IBE-IBD differentially expressed genes.
View article: Data from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Data from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
The abundance and functional orientation of tumor-infiltrating lymphocytes in breast cancer is associated with distant metastasis-free survival, yet how this association is influenced by tumor phenotypic heterogeneity is poorly understood.…
View article: Supplementary Table S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Table S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Assessment of the prognostic significance of the IMM as a function of intrinsic subtype and proliferation tertile.
View article: Supplementary Methods from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Methods from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Detailed description of methods.
View article: Supplementary Methods from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Methods from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Detailed description of methods.
View article: Supplementary Table S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Table S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Clinical characteristics of the breast cancer cohorts.
View article: Supplementary Figure S4 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S4 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Subgroup analysis in IBE and IBD tumors. Kaplan-Meier plots comparing the probability of DMFS of patients classified as FID, WID and PID.
View article: Supplementary Table S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Table S2 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Assessment of the prognostic significance of the IMM as a function of intrinsic subtype and proliferation tertile.
View article: Supplementary Table S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Table S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Clinical characteristics of the breast cancer cohorts.
View article: Supplementary Figure S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S1 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
The B/P, T/NK and M/D immune metagenes are coordinately expressed in breast tumors and leukocytes but not in breast cancer cell lines.
View article: Supplementary Figure S3 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
Supplementary Figure S3 from Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness Open
Differential abundance of immune cell infiltrate in FID and PID breast tumors.